The
Shuman Law Firm announces that it is investigating potential claims
against certain officers and directors of DaVita HealthCare Partners
Inc. (“DaVita” or the “Company”) (NYSE: DVA).
DaVita is a Denver, Colorado-based company that provides kidney dialysis
services for patients suffering from chronic kidney failure or end stage
renal disease.
The Firm’s investigation relates to a U.S. Department of Justice
announcement that DaVita had agreed to pay $350 million for allegedly
violating several provisions of the False Claims Act, including
persuading physicians to refer patients to DaVita by offering kickbacks.
The Company has also agreed to a Civil Forfeiture of $39 million, based
upon conduct related to joint venture transactions entered into in
Colorado.
If you currently own DaVita common stock and are interested in
discussing your rights, or have information relating to this
investigation, please contact Kip B. Shuman or Rusty E. Glenn at (303)
861-3003 or email Mr. Shuman at kip@shumanlawfirm.com
or email Mr. Glenn at rusty@shumanlawfirm.com.
The Shuman Law Firm represents investors throughout the nation,
concentrating its practice in stockholder litigation.
Copyright Business Wire 2015